Drugs / SHR-6934
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06700083 | Jan 2025 → May 2026 | heart failure | Beijing Suncadia Pharmaceuticals Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHR-6934 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06700083 ↗ |
| Route | Subcutaneous | “Subcutaneous Injections” NCT06700083 ↗ |